These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30612919)

  • 21. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new ballgame: comprehensive medication review.
    McSpadden C
    Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulating comprehensive medication reviews among Medicare Part D beneficiaries.
    Doucette WR; Pendergast JF; Zhang Y; Brown G; Chrischilles EA; Farris KB; Frank J
    Am J Manag Care; 2015 Jun; 21(6):e372-8. PubMed ID: 26247578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
    Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
    J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
    Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
    Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The certainty in consumers' willingness to accept pharmacist-provided medication therapy management services.
    Brown LM; Rashrash ME; Schommer JC
    J Am Pharm Assoc (2003); 2017; 57(2):211-216. PubMed ID: 28285775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing community pharmacists' likelihood to ask medication monitoring questions: A factorial survey.
    Witry MJ; Doucette WR
    Res Social Adm Pharm; 2015; 11(5):639-50. PubMed ID: 25573019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived value of a home-based medication therapy management program for the elderly.
    Moultry AM; Poon IO
    Consult Pharm; 2008 Nov; 23(11):877-85. PubMed ID: 19072012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
    Urmie JM; Farris KB; Doucette WR; Goedken AM
    J Am Pharm Assoc (2003); 2011; 51(1):72-81. PubMed ID: 21247829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
    Murugappan MN; Seifert RD; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Medication Review Completion in Medically Underserved Areas and Populations.
    Le LD; Paulk IR; Axon DR; Bingham JM
    J Health Care Poor Underserved; 2021; 32(3):1301-1311. PubMed ID: 34421032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in state Medicaid medication management initiatives.
    Neyarapally GA; Smith MA
    Res Social Adm Pharm; 2017; 13(1):214-223. PubMed ID: 26972951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community pharmacist-child medication communication: magnitude, influences, and content.
    Nilaward W; Mason HL; Newton GD
    J Am Pharm Assoc (2003); 2005; 45(3):354-62. PubMed ID: 15991757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing and resolving drug therapy problems by understanding patients' medication experiences.
    Ramalho-de Oliveira D; Shoemaker SJ; Ekstrand M; Alves MR
    J Am Pharm Assoc (2003); 2012; 52(1):71-80. PubMed ID: 22257619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive medication reviews: Optimal delivery setting and recommendations for quality assessment.
    Farhat NM; Farris KB; Patel MR; Cornish L; Choe HM
    J Am Pharm Assoc (2003); 2019; 59(5):642-645. PubMed ID: 31307965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of patients' perceptions of the listening skills of the pharmacist on their willingness to re-use Home Medicines Reviews: a structural equation model.
    Carter SR; Moles R; White L; Chen TF
    Res Social Adm Pharm; 2015; 11(2):163-75. PubMed ID: 25681299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.